Experimental cell therapy targets aggressive lymphoma that returns after treatment
Disease control
Terminated
This study aimed to test a personalized cell therapy called axicabtagene ciloleucel for adults with a specific type of lymphoma that has come back or did not respond to initial treatment. The goal was to see if this therapy could control the disease and how safe it was. The trial…
Phase: PHASE2 • Sponsor: Universität Münster • Aim: Disease control
Last updated Apr 01, 2026 14:42 UTC